🇪🇪 Medical cannabis in Estonia

Model D — named-patient / exceptional access. Cannabis is not a separate medical category in Estonia; it is handled like any other medicine without a marketing authorisation.

Ravimiamet (State Agency of Medicines) states that standardised cannabis and cannabinoid-containing medicines are available to Estonian patients 'analogously to other unauthorised medicines' (müügiloata ravimid). The doctor files a justified application (normally as a digital prescription in the Retseptikeskus with a justification field) and Ravimiamet issues a positive or negative decision per patient. Cultivation of cannabis for medical use is prohibited. No cannabis-specific law, register or programme exists.

Source: Ravimiamet — Kanep, THC, CBD (Cannabis, THC, CBD) · read 27 September 2026

Epidyolex (cannabidiol) is the only cannabis-derived medicine with an Estonian marketing authorisation. Any other product — nabiximols, dronabinol, standardised cannabis flower or extracts — can only be requested per patient as an unauthorised medicine.

Ravimiamet: 'Ainus ravim, mis sisaldab CBD-d peamise toimeainena ja mis omab Eestis müügiluba, on Epidiolex' (page updated 10.07.2025). Medical cannabis is defined by the agency as either industrially produced medicines containing natural or synthetic cannabinoids or standardised cannabis drug produced for medical use; both fall under the unauthorised-medicine route. The agency's standing list of active substances pre-approved on request of specialist societies (Ravimiseadus § 21 lg 7 p 1, last updated 18.07.2022) contains no cannabis, THC, dronabinol, nabilone or nabiximols entry, so each cannabis request is an individual one. Whether Sativex holds an Estonian authorisation could not be verified in this session (the medicines register search is closed to automated access).

Source: Ravimiamet — Ravimiameti kasutamiseks lubatud müügiloata ravimite toimeained (list of active substances of unauthorised medicines approved on specialist-society request) · read 27 September 2026

Any treating doctor in Estonia may apply; there is no list of authorised cannabis prescribers and no specialist requirement is published. The decision rests with Ravimiamet.

The unauthorised-medicine procedure allows an application by a doctor for an individual patient, by a doctor of a healthcare institution for use in that institution, or by a professional society for defined diagnoses. Ravimiamet processes the application and decides 'enamikel juhtudel kuni 14 päevaga, maksimaalselt võib kuluda 30 päeva'. Until 2017 a separate committee opinion was required for cannabis requests; today the agency page describes no cannabis-specific committee step (historical detail not verified against primary law in this session).

Source: Ravimiamet — Müügiloata ravimid (Unauthorised medicines) · read 27 September 2026

A digital prescription in the national Retseptikeskus flagged as an unauthorised-medicine request; it becomes dispensable only after Ravimiamet's positive decision. Narcotic medicines can be prescribed for at most 30 days of treatment.

The doctor selects a justification from a fixed list in the digital prescription; a digitally signed paper application is allowed only exceptionally. Status values are 'Otsus positiivne', 'Otsuse ootel', 'Otsus negatiivne'. After a positive decision the pharmacy reserves the prescription; the reservation is valid 90 days during which the pharmacy orders the product. For narcotic medicines Ravimiamet states: 'Arst võib retseptiga välja kirjutada narkootilise ravimi kuni 30 päevaseks raviks'. THC-containing products fall under the Narkootiliste ja psühhotroopsete ainete ning nende lähteainete seadus (Act on Narcotic and Psychotropic Substances and their Precursors) and sotsiaalministri määrus nr 73 (schedules).

Source: Ravimiamet — Narkootiliste ja psühhotroopsete ainete käitlemine (handling of narcotic and psychotropic substances) · read 27 September 2026

Not published. Estonian rules on remote consultations and digital prescribing are not cannabis-specific, and no official page states whether an unauthorised-medicine application may be initiated after a video consultation.

The unauthorised-medicine application is filed by the doctor in the Retseptikeskus and requires the doctor to inform the patient about the medicine; Ravimiamet's pages do not address the consultation format. No regulator statement found that either permits or forbids starting cannabis treatment via telemedicine.

Source: Ravimiamet — Müügiloata ravimid (Unauthorised medicines) · read 27 September 2026

Any licensed community pharmacy can dispense after a positive decision; the pharmacy orders the product from a wholesaler and tells the patient when it arrives. Narcotic medicines may not be sent by post.

Ravimiamet: on a positive decision the pharmacist reserves the prescription (valid 90 days), orders from a wholesaler quoting prescription number, product and pack count, and notifies the patient. All licensed pharmacies are listed in the activity-licence register (rkav.tehik.ee) and on the pharmacy map apteegid.ravimiamet.ee. Posting narcotic/psychotropic substances is prohibited according to the agency's narcotics page. No pharmacy compounding of cannabis preparations is described.

Source: Ravimiamet — Apteek (Pharmacy) · read 27 September 2026

Not published for cannabis. Ravimiamet's unauthorised-medicine page does not mention Tervisekassa (Health Insurance Fund) reimbursement, and no official statement on reimbursement of cannabis-based unauthorised medicines was found.

Reimbursement in Estonia depends on a product being on the Tervisekassa reimbursement list; unauthorised medicines obtained per patient are generally paid by the patient unless separately listed. Whether any cannabis-based product (including Epidyolex) is reimbursed could not be verified from an official page in this session.

Source: Ravimiamet — Müügiloata ravimid (Unauthorised medicines) · read 27 September 2026

No public price. Unauthorised medicines are priced by the importing wholesaler and pharmacy per order; no regulator price list exists for cannabis products.

Ravimiamet publishes no prices for unauthorised medicines; the pharmacy quotes the price when the product is ordered from the wholesaler.

Source: Ravimiamet — Müügiloata ravimid (Unauthorised medicines) · read 27 September 2026

Estonia prohibits driving under the influence of narcotic substances without a numeric THC limit; no medical exemption for prescribed THC is published by the regulator. The statute text (Liiklusseadus) could not be opened in this session, so treat this as unverified.

The relevant provisions are Liiklusseadus (Traffic Act) § 69 on driving in a state of intoxication and the penal provisions on driving under the influence of narcotic or psychotropic substances. Riigi Teataja (the State Gazette) returned only a JavaScript notice to every request in this session, so the current wording, the definition of narcotic intoxication and any medical-use defence were not verified. Ravimiamet's cannabis and narcotics pages contain no guidance on driving.

Source: Ravimiamet — Kanep, THC, CBD (Cannabis, THC, CBD) — no driving guidance · read 27 September 2026

Inside Schengen you need a Schengen certificate (Art. 75) for any narcotic medicine, maximum 30 days' supply; Estonian pharmacies issue it for 5 euros to Estonian residents. From outside Schengen you may bring the quantity prescribed and dispensed to you with the prescription or a doctor's note.

Ravimiamet: 'Reisides Schengeni riiki koos narkootiliste ja psühhotroopsete ravimitega, vajate Schengeni tunnistust, sõltumata kaasavõetavast ravimi kogusest'; the certificate covers at most a 30-day treatment quantity and can be requested at any pharmacy for 5 euros; only persons with permanent residence in Estonia can obtain the Estonian certificate. Travellers arriving from non-Schengen countries with narcotic medicines carry 'the amount prescribed and issued' plus an electronic prescription printout, paper prescription copy or doctor's certificate. Ordinary prescription medicines: the quantity prescribed by the doctor. OTC: up to 10 different medicines, 5 packs each. Posting narcotic medicines is prohibited.

Source: Ravimiamet — Ravimitega reisimine (Travelling with medicines) · read 27 September 2026

No law bars a non-resident from being treated, but the pathway runs through an Estonian doctor's application in the national e-prescription system, so in practice it is built for people with an Estonian personal code. Foreign prescriptions for narcotic or unauthorised medicines cannot be dispensed in Estonia; bring your own medicine with a Schengen certificate instead.

1) Prescribing to non-residents: no residency condition is published, but the unauthorised-medicine request is filed as a digital prescription in the Retseptikeskus by an Estonian-licensed doctor and the pharmacy dispenses against the patient's identity; Ravimiamet does not publish a rule for patients without an Estonian personal code — not published. 2) Prescriptions from other EU/EEA countries: the cross-border e-prescription service run by TEHIK excludes 'narkootilisi ja psühhotroopseid ravimeid', anabolic steroids, extemporaneous preparations and medicines without a valid Estonian authorisation — so THC products and unauthorised cannabis medicines from abroad are not dispensable via e-prescription (this is the Art. 11(6) exclusion in practice). The paper-prescription rule in the ministerial regulation on prescribing and dispensing could not be opened (Riigi Teataja blocked) — not verified. 3) Bringing medicine in: Schengen Art. 75 certificate, max 30 days, for Schengen residents; non-Schengen arrivals carry the prescribed and dispensed quantity with prescription/doctor's note; no Estonian import permit is described for personal quantities. 4) Foreign telemedicine prescriptions: fall under 2) — a foreign prescription for a narcotic or unauthorised medicine cannot be filled in Estonia.

Source: TEHIK — Piiriülene digiretsept (Cross-border digital prescription) · read 27 September 2026

No pending change was found on the regulator's pages; the cannabis page was last updated 10 July 2025 and still describes only the unauthorised-medicine route.

Ravimiamet's cannabis page (updated 10.07.2025) and unauthorised-medicine page describe the current per-patient procedure without announcing any programme, register or legislative amendment. Whether any bill is before the Riigikogu could not be checked against the parliament's site in this session.

Source: Ravimiamet — Kanep, THC, CBD (Cannabis, THC, CBD) · read 27 September 2026

No official count of cannabis patients or approved applications is published. Ravimiamet's statistical yearbook 2025 contains no cannabis, THC or unauthorised-medicine application figures.

The agency yearbook (Ravimiamet aastaraamat 2025) reports consumption by ATC group and pharmacy statistics; it does not break out unauthorised-medicine applications or cannabis products. No other official series was found.

Source: Ravimiamet — Ravimiameti statistikaraamatud (statistical yearbooks) · read 27 September 2026